Isolated limb perfusion for unresectable extremity sarcoma (original) (raw)
Isolated limb perfusion with tumor necrosis factor-? and melphalan for patients with unresectable soft tissue sarcoma of the extremities
Frits van Coevorden
Cancer, 2003
View PDFchevron_right
Isolated Limb Perfusion in the Treatment of Advanced Soft-tissue Sarcomas
Martin Malawer
Musculoskeletal Cancer Surgery, 2004
View PDFchevron_right
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma
Alexander Eggermont
2007
View PDFchevron_right
Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs
J. de Wilt
Annals of Surgical Oncology, 2005
View PDFchevron_right
4 Isolated Limb Perfusion in the Treatment of Advanced
Mordechai Gutman
2014
View PDFchevron_right
Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities
Peter Kam, Hidde Kroon
Current problems in surgery, 2011
View PDFchevron_right
Technology Insight: utility of TNF-α-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities
J. de Wilt
Nature Clinical Practice Oncology, 2006
View PDFchevron_right
Isolated limb perfusion with tumor necrosis factor and melphalan for non‐resectable soft tissue sarcomas: Long‐term results on efficacy and limb salvage in a selected …
Robert van Ginkel
Journal of surgical …, 2008
View PDFchevron_right
Isolated Limb Perfusion: What Is the Evidence for Its Use?
Frits van Coevorden
Annals of Surgical Oncology, 2004
View PDFchevron_right
Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage
Alexander Eggermont
Annals of Oncology, 2004
View PDFchevron_right
Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas
Alexander Eggermont
Annals of Surgery, 1996
View PDFchevron_right
Long-Term Results of Tumor Necrosis Factor - and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
J. de Wilt
Journal of Clinical Oncology, 2011
View PDFchevron_right
Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities
François Mosimann
European Journal of Surgical Oncology, 2000
View PDFchevron_right
Treatment of Recurrent Sarcoma of the Extremities by Isolated Limb Perfusion Using Tumor Necrosis Factor Alpha and Melphalan
Renato Manzi
Tumori Journal, 1996
View PDFchevron_right
A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity
Mary Brady
Annals of Surgical Oncology, 2006
View PDFchevron_right
A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US
Rebecca Petersen
Journal of the American College of Surgeons, 2009
View PDFchevron_right
Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
Mordechai Gutman
European Journal of Surgical Oncology (EJSO), 2009
View PDFchevron_right
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan
Renato Manzi
Cancer, 1994
View PDFchevron_right
Limb desmoid tumors: A possible role for isolated limb perfusion with tumor necrosis factor–alpha and melphalan
Mordechai Gutman
Surgery, 1999
View PDFchevron_right
TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome
Robert van Ginkel
Journal of Surgical Oncology, 2011
View PDFchevron_right
Minimally invasive isolated limb perfusion – technical details and initial outcome of a new treatment method for limb malignancies
D. Katsarelias
International Journal of Hyperthermia
View PDFchevron_right
Fifty Tumor Necrosis Factor?Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors
Alexander Eggermont
Annals of Surgical Oncology, 2003
View PDFchevron_right
Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
Eric Manusama
British journal of cancer, 1999
View PDFchevron_right
Isolated limb infusion: A review
Hidde Kroon
Journal of Surgical Oncology, 2009
View PDFchevron_right
Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity
Eric Manusama
Ejso, 1999
View PDFchevron_right
Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity
Fernanda Oliveira
Clinics (São Paulo, Brazil), 2012
View PDFchevron_right
Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion
Rebecca Petersen
Annals of Surgical Oncology, 2008
View PDFchevron_right
Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity
Hidde Kroon
Annals of Surgical Oncology, 2008
View PDFchevron_right
Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety
Luis De La Cruz-merino
The Oncologist, 2010
View PDFchevron_right
Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient
Françoise Rimareix
Annals of Surgical Oncology, 2009
View PDFchevron_right